Comparison Overview
Novoheart

Novoheart
6 Tide St, 2nd Floor, Boston, 02210, US
Last Update: 28/12/2025
Novoheart, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is responsible for Disease Modelling & Drug Discovery using our proprietary award-winning mini-Heart Technology, which offers a range of bioengineered human heart constru...

Roche
Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH
Last Update: 28/06/2026
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...
Compliance Ranges Comparison

Novoheart







Roche






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Novoheart in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche in 2026.
Incident History - Novoheart (X = Date, Y = Severity)
Novoheart cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Roche (X = Date, Y = Severity)
Roche cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Novoheart

Roche
FAQ
Latest Global CVEs
Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.
Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.
Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.
Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.
Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.